The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Clinical outcome of erythema migrans after treatment with phenoxymethyl penicillin

På svenska

Author

Summary, in English

In a 5 y retrospective follow-up study in southern Sweden of 708 adult individuals with erythema migrans as the single manifestation of Lyme borreliosis, the clinical outcome and the antibiotic treatment were studied. 80%, were treated with phenoxymethyl penicillin, 15% with doxycycline and 5% with other antibiotics. Phenoxymethyl penicillin and doxycycline were extremely effective: 98 and 94% of the individuals reported complete recovery without complications. Few individuals reported the development of new symptoms following treatment and none developed any late manifestation of Lyme borreliosis during the observation period. Thus, in the area studied the treatment of the early localized manifestation of Lyme borreliosis (erythema migrans) with antibiotics was extremely successful. The current Swedish recommendation to use phenoxymethyl penicillin, when no sign of disseminated infection or coinfection with other tick-borne pathogens is present, seems excellent.

Publishing year

2003

Language

English

Pages

129-131

Publication/Series

Scandinavian Journal of Infectious Diseases

Volume

35

Issue

2

Document type

Journal article (comment)

Publisher

Informa Healthcare

Topic

  • Infectious Medicine

Status

Published

Project

  • Erythema Migrans in Primary Health Care

Research group

  • Family Medicine and Community Medicine

ISBN/ISSN/Other

  • ISSN: 1651-1980